| |
|
|
| Name: |
CHARLEMAGNE CAPITAL LTD |
| City: |
DOUGLAS, ISLE OF MAN |
| State: |
XX |
| Zip: |
IM1 1EN |
| |
|
|
| Achive
data |
| View
Filing Period: |
|
|
|
|
|
|
 |
Download |
|
|
| |
| |
|
Free Registration Required For Full Results
|
|
|
| Holdings
Found :
13 |
|
View All Holdings |
Currently
Viewing:
Unchanged Positions |
|
|
Page 1 of 1 |
Menu
 |
Ticker |
Company Name |
Position
Rank |
New/Closed
Postion |
Last
Close |
Value |
Shares Held |
% of
Portfolio |
Value
Change |
Change In
Shares Held |
% of Company |
Industry |
|
GILD |
Gilead Sciences Inc |
23 |
- |
$64.78 |
$441,000 |
6,472 |
0.21% |
-21,000 |
0 |
0 |
Biotechnology |
|
|
PEN |
Penumbra Inc |
24 |
- |
$208.55 |
$355,000 |
4,230 |
0.17% |
87,000 |
0 |
0.014 |
N/A |
|
|
MRK |
Merck & Co Inc |
25 |
- |
$131.20 |
$344,000 |
5,412 |
0.16% |
26,000 |
0 |
0 |
Drug Manufacturers - ... |
|
|
PFE |
Pfizer Inc |
26 |
- |
$27.81 |
$290,000 |
8,466 |
0.14% |
16,000 |
0 |
0 |
Drug Manufacturers - ... |
|
|
AMGN |
Amgen Inc |
28 |
- |
$311.29 |
$268,000 |
1,633 |
0.13% |
30,000 |
0 |
0 |
Biotechnology |
|
|
LLY |
Eli Lilly & Co |
29 |
- |
$734.97 |
$264,000 |
3,135 |
0.12% |
34,000 |
0 |
0 |
Drug Manufacturers - ... |
|
|
CELG |
Celgene Corp |
31 |
- |
$108.24 |
$252,000 |
2,026 |
0.12% |
18,000 |
0 |
0 |
Drug Manufacturers - ... |
|
|
NBIX |
Neurocrine Biosciences Inc |
32 |
- |
$140.71 |
$242,000 |
5,584 |
0.11% |
27,000 |
0 |
0.006 |
Biotechnology |
|
|
BMY |
Bristol-Myers Squibb Co |
33 |
- |
$43.99 |
$237,000 |
4,347 |
0.11% |
-16,000 |
0 |
0 |
Drug Manufacturers - ... |
|
|
ARWR |
Arrowhead Pharmaceuticals Inc |
34 |
- |
$24.44 |
$193,000 |
102,815 |
0.09% |
34,000 |
0 |
0.171 |
Business Services |
|
|
AKRX |
Akorn Inc |
36 |
- |
$0.03 |
$187,000 |
7,763 |
0.09% |
18,000 |
0 |
0.008 |
Diagnostic Substances |
|
|
LCI |
Lannett Co Inc |
37 |
- |
$0.65 |
$142,000 |
6,323 |
0.07% |
4,000 |
0 |
0.018 |
Drug Manufacturers - ... |
|
|
AMRN |
Amarin Corp Plc |
38 |
- |
$0.91 |
$121,000 |
37,880 |
0.06% |
5,000 |
0 |
0.022 |
Drug Manufacturers - ... |
|
